Wealth Enhancement Advisory Services, LLC Ptc Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,670 shares of PTCT stock, worth $581,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,670Holding current value
$581,632% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
268Shares Held
72.6MCall Options Held
180KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$457 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$387 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$368 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$318 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$164 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.57B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...